• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人-人杂交瘤在无血清培养基中产生抗体。

Antibody production by human X human hybridomas in serum-free medium.

作者信息

Cole S P, Vreeken E H, Roder J C

出版信息

J Immunol Methods. 1985 Apr 22;78(2):271-8. doi: 10.1016/0022-1759(85)90085-7.

DOI:10.1016/0022-1759(85)90085-7
PMID:3989311
Abstract

Four human X human hybridomas were adapted to growth in serum-free medium consisting of RPMI 1640 supplemented with bovine serum albumin and transferrin (BSA/Tf medium). Production of specific monoclonal antibodies was maintained for more than 2 months. Although the maximal cell density achieved was lower than that in serum-supplemented medium, immunoglobulin production was similar or higher when results were expressed on a per viable cell basis. Thus it is feasible to grow human X human hybridomas in serum-free culture and it is possible that this will become the method of choice for large scale production of human monoclonal antibodies.

摘要

将四个人源人杂交瘤细胞适应于在由添加了牛血清白蛋白和转铁蛋白的RPMI 1640组成的无血清培养基(BSA/Tf培养基)中生长。特异性单克隆抗体的产生维持了两个多月。尽管达到的最大细胞密度低于补充血清的培养基中的密度,但以每活细胞为基础表达结果时,免疫球蛋白的产生相似或更高。因此,在无血清培养中培养人源人杂交瘤细胞是可行的,并且这有可能成为大规模生产人单克隆抗体的首选方法。

相似文献

1
Antibody production by human X human hybridomas in serum-free medium.人-人杂交瘤在无血清培养基中产生抗体。
J Immunol Methods. 1985 Apr 22;78(2):271-8. doi: 10.1016/0022-1759(85)90085-7.
2
Optimization of growth and secretion of human monoclonal antibodies by hybridomas cultured in serum-free media.
Hybridoma. 1991 Jun;10(3):401-9. doi: 10.1089/hyb.1991.10.401.
3
Effective production of anti-tetanus toxoid and anti-HBsAg human monoclonal antibodies by serum-free culture of hybridomas.通过杂交瘤细胞的无血清培养有效生产抗破伤风类毒素和抗乙肝表面抗原人单克隆抗体。
Cytotechnology. 1991;5 Suppl 2:S53-74.
4
Growth of human-human hybridomas in serum-free media enhances antibody secretion.人-人杂交瘤在无血清培养基中的生长可增强抗体分泌。
In Vitro Cell Dev Biol. 1987 Nov;23(11):745-9. doi: 10.1007/BF02623674.
5
Characterization of human hybridomas secreting antibody to tetanus toxoid.分泌破伤风类毒素抗体的人杂交瘤细胞的特性分析
Proc Natl Acad Sci U S A. 1983 Oct;80(20):6376-80. doi: 10.1073/pnas.80.20.6376.
6
Hybridoma cell growth and anti-neuroblastoma monoclonal antibody production in spinner flasks using a protein-free medium with microcarriers.使用含微载体的无蛋白培养基在转瓶中培养杂交瘤细胞并生产抗神经母细胞瘤单克隆抗体。
J Biotechnol. 1999 Feb 19;68(2-3):213-26. doi: 10.1016/s0168-1656(98)00208-9.
7
Growth kinetics of hybridoma cells: (1) The effects of varying foetal calf serum levels.杂交瘤细胞的生长动力学:(1) 不同胎牛血清水平的影响。
Dev Biol Stand. 1985;60:17-24.
8
Feasibility studies of large scale production of human anti-tetanus toxoid monoclonal antibodies.大规模生产人抗破伤风类毒素单克隆抗体的可行性研究。
J Biotechnol. 1999 Jan 22;67(2-3):205-16. doi: 10.1016/s0168-1656(98)00182-5.
9
Human anti-tetanus toxoid monoclonal antibody secreted by EBV-transformed human B cells fused with murine myeloma.由EB病毒转化的人B细胞与鼠骨髓瘤细胞融合分泌的人抗破伤风类毒素单克隆抗体。
Hybridoma. 1982;1(3):323-8. doi: 10.1089/hyb.1.1982.1.323.
10
Preparation of human-mouse heterohybridomas against an immunising antigen.制备针对免疫抗原的人-鼠异种杂交瘤。
J Immunol Methods. 2000 Dec 1;246(1-2):187-202. doi: 10.1016/s0022-1759(00)00293-3.

引用本文的文献

1
Substitution of transferrin by FeCl3 in the development of a low foetal calf serum concentration medium for KB-26.5 hybridoma cell line.在开发用于KB - 26.5杂交瘤细胞系的低胎牛血清浓度培养基过程中用三氯化铁替代转铁蛋白。
Cytotechnology. 1993;13(2):133-41. doi: 10.1007/BF00749940.
2
Growth of human-human hybridomas in serum-free media enhances antibody secretion.人-人杂交瘤在无血清培养基中的生长可增强抗体分泌。
In Vitro Cell Dev Biol. 1987 Nov;23(11):745-9. doi: 10.1007/BF02623674.
3
Hybridoma technology: new developments of practical interest.
杂交瘤技术:具有实际意义的新进展。
J Immunol Methods. 1987 Aug 3;101(2):153-70. doi: 10.1016/0022-1759(87)90147-5.